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Objective: Although SPECT/CT systems have been used for sentinel lymph 
node (SLN) imaging, few studies have focused on optimization of attenuation 
correction (AC) and scatter correction (SC). While SLNs could be detected in 
conventional planar images, they sometimes do not appear in SPECT/CT 
images. The purpose of this study was to investigate the optimal AC and SC 
and to improve the detectability of SLNs in examinations using SPECT/CT 
systems. 
Materials and methods: The study group consisted of 56 female patients with 
breast cancer. In SPECT/CT imaging, four kinds of images were created with 
and without AC and SC; namely, AC-SC-, AC+SC-, AC-SC+ and AC+SC+. 
Five nuclear medicine physicians interpreted the planar and SPECT/CT 
images with five grades of confidence levels (1 to 5). The detection rate was 
calculated as the number of patients whose average confidence levels of 
interpretation were more than 4, divided by the total number of patients. 
Results: The confidence level of interpretation and the detection rate 
provided by the planar images were 4.76 ± 0.49 and 94.6%, respectively. In 
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SPECT/CT imaging, the AC+SC- provided the best detection rate (confidence 
level of interpretation, 4.81 ± 0.38; detection rate, 98.2%), followed by the 
AC-SC- (4.70 ± 0.55, 89.3%), and the AC-SC+ (4.39 ± 1.2, 78.6%). The lowest 
values were obtained for the AC+SC+ (4.36 ± 1.22, 78.6%). Regarding the 
confidence levels of interpretation, significant differences were observed 
between AC+SC- and AC-SC-, AC+SC- and AC+SC+, AC+SC- and AC-SC+, 
and between planar images and AC+SC+ (P ＝ 0.0021, 0.0009, 0.0013, and 
0.0056, respectively).  
Conclusions: When SPECT/CT was used, AC improved the detection of SLNs. 
SC caused disappearance of a faint SLN in some cases and should not be 
performed. 
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Visualization and localization of sentinel lymph nodes (SLNs) on 
lymphoscintigraphy is enhanced by the use of single-photon emission 
computed tomography/computed tomography (SPECT/CT) systems, 
particularly when drainage to lymph nodes is unpredictable, SLNs are close 
to the injection sites, extra-axillary SLNs are present, or SLNs are not 
identified on conventional planar images because of excessive soft tissue 
attenuation. Although detailed studies have been published on improvement 
of SLN localization with SPECT/CT systems [1-7], few studies have focused 
on attenuation correction (AC) and scatter correction (SC). Because of the 
scattering of gamma rays, it becomes difficult to identify the SLNs when 
they lie close to the injection sites. Since it is difficult to detect deeply 
situated SLNs because of the attenuation of gamma rays, we applied AC and 
SC. A faint SLN, however, sometimes disappeared in SPECT/CT images and 
the detectability of SLNs may worsen compared with that on planar images. 
Moreover, these corrections might cause artifacts near the injection sites. 
Thus, the purpose of this study was to investigate the optimal AC and SC 
and to improve the detection of SLNs in breast cancer patients. 
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MATERIALS AND METHODS 
The study group consisted of 56 consecutive female patients (age, 
56.1 ± 13.1 years) with histologically diagnosed breast cancer from November 
2013 to July 2014. One patient was excluded because written informed 
consent was not obtained. Tumors were located on the right side in 22 cases 
and the left side in 32 cases, and were present on both sides in two cases. A 
37 MBq (1mCi) dose of Technetium-99m (Tc-99m) phytate (FUJIFILM RI 
Pharma Co. Ltd., Japan) was injected subcutaneously around the tumor. 
Location markers containing 0.3 MBq (8.1μCi) of Tc-99m pertechnetate were 
placed at the center of the sternal notch and the xiphoid process. Planar 
imaging was performed at 10 min and 3－4 h after the injection. A dual -head 
gamma camera equipped with a low-to-medium energy general-purpose 
(LMEGP) collimator (Symbia T6; Siemens, Erlangen, Germany) was used for 
planar imaging. The counts in the planar image were acquired for 6 min in a 
256 × 256 matrix with the LMEGP collimator. The injection sites were not 
covered with a lead shield. The energy was centered at 140 keV with a 20% 
window for Tc-99m. When the SLNs were not detected clearly such as at the 
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injection sites located near the axilla lymph nodes, the planar images were 
acquired from another direction. SPECT/CT imaging was performed after 
3–4 h of planar imaging. The SPECT/CT system (Symbia T6; Siemens, 
Erlangen, Germany) used for imaging consisted of a dual-head gamma 
camera equipped with an LMEGP collimator and a multi-detector spiral CT 
optimized for rapid rotation. SPECT data were acquired in a 128 × 128 
matrix for 20 sec each, for a total of 60 frames in steps of 6° over 360°. The 
energy was centered at 140 keV with a 15% window in SPECT/CT imaging. 
The scatter correction method was the dual energy window method [8,9]. The 
pixel truncation method was used to exclude the effects of high-level activity 
at the injection sites. The cutoff value was 100 counts in most cases, 
although it was changed as required in some cases. The data were 
reconstructed by using an iterative method based on an ordered subset 
expectation maximization algorithm with 12 iterations and 15 subsets using 
the resolution correction. A Gaussian filter was not used for smoothing. Four 
kinds of images were created with and without AC and SC; namely, AC-SC-, 
AC+SC-, AC-SC+ and AC+SC+. The attenuation coefficient was 0.15 cm-1. A 
CT scan was obtained under the following conditions: tube voltage of 130 kVp, 
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product of tube current and time of 50 mA, slice thickness of 2.5 mm, and 
reconstruction kernels of B35s kernel. Both SPECT and CT axial slices (slice 
thickness, 5 mm) were generated using the e.soft application package 
(Siemens), which was also used for fusing the CT and SPECT images. 
Maximum intensity projection (MIP) images were generated to identify the 
SLNs. 
Interpretation of images 
Five nuclear medicine physicians evaluated the planar and 
SPECT/CT images and recorded the degrees of confidence in interpreting the 
presence or absence of SLNs on images. The confidence levels of 
interpretation were evaluated using a five-grade scale: 1, definitely not 
identified; 2, probably not identified; 3, equivocal; 4, probably identified; and 
5, definitely identified. The detection rate was calculated as the number of 
patients whose average confidence levels of interpretation were more than 4, 
divided by the total number of patients. The confidence levels among the 
planar images and the SPECT/CT images (AC+SC+, AC-SC-, AC+SC-, and 
AC-SC+) were compared using the Wilcoxon signed-rank test. Statistical 
significance was defined as p < 0.01. Regions of interest were placed on SLNs 
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in SPECT/CT images. We compared the counts of SLNs among AC+SC+, 
AC-SC-, AC+SC-, and AC-SC+. The effect of SC was evaluated using the 
following equation: effect of SC = (the counts decreased by the SC) × 100 / 
(the counts obtained without SC). The effect of AC was evaluated using the 
following equation: effect of AC = (the counts increased by the AC) × 100 / 
(the counts obtained without AC). Before examination, approval for the 
study protocol was obtained from the institution’s ethical committee and 
written informed consent was obtained from the patients. 
 
RESULTS 
The confidence levels of interpretation and the detection rate 
provided by the planar images were 4.78 ± 0.49 and 94.6%, respectively. The 
confidence levels of interpretation and the detection rate in planar and 
SPECT/CT images are shown in Fig. 1 and Table 1. The detection rate 
provided by the AC+SC- was the best (confidence level of interpretation, 4.81 
± 0.38; detection rate, 98.2%), followed by the AC-SC- (4.70 ± 0.55, 89.3%), 
and the AC-SC+ (4.39 ± 1.17, 78.6%). The values for the AC+SC+ were the 
lowest (4.36 ± 1.22, 78.6%). Significant differences were observed between 
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AC+SC- and AC-SC-, AC+SC- and AC+SC+, AC+SC- and AC-SC+, and 
between planar images and AC+SC+ (P ＝ 0.0021, 0.0009, 0.0013, and 
0.0056, respectively). The SLN count provided by the AC+SC- was the 
highest (11426 ± 14214; median, 6123 counts), followed by those of the 
AC+SC+ (8869 ± 14408; median, 3135 counts), and the AC-SC- (4904 ± 5833; 
median, 2924 counts). The AC-SC+ counts were the lowest (3804 ± 5854; 
median, 1884 counts) (Table 2). The average distance from SLNs to the body 
surface was 2.6 ± 1.3 cm (median, 2.2 cm). The distance from SLNs to body 
surface and an effect of AC have a fair correlation (R2 = 0.464) (Fig. 2). The 
counts of SLNs, especially deeply situated SLNs, increased when using the 
AC. When the nodes were close to the body surface, the effects of AC were 
less significant. In some cases, an artifact occurred as a result of the AC on 
the border of the lung and the breast. The average distance from injection 
sites to SLNs was 7.6 ± 2.6 cm (median, 7.3 cm). The distance from 
injection sites to SLNs and the effect of the SC showed a fair correlation (R2 = 
0.433) (Fig. 3). The counts of SLNs decreased when using the SC, especially 
near the injection sites. A faint SLN disappeared as a result of the SC (Fig. 4). 
The counts of SLNs increased when using the AC, especially in deeply 
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situated SLNs (Fig. 5). In one case, while SLNs could not be detected clearly 
in both the planar image and the SPECT/CT fused image, these lymph nodes 
could be identified with the gamma probe during surgery (Fig. 6). Since the 
SLNs could not be clearly detected in the planar image at 3 hours after 
injection, the SPECT/CT images were acquired after confirming regional 
movement by massage of injection sites (Fig. 7). The anatomical information 
of the CT made a precise localization of the SLNs possible. The SPECT/CT 
images helped to rule out artifacts from the injection site and questionable 
contamination, which was sometimes seen during injection. Although the 
SLNs near injection sites could not be clearly identified in the planar image, 
they were identified in the SPECT/CT fused images (Fig. 8). 
 
DISCUSSION 
Many researchers have reported that the SPECT/CT provided 
additional value in determination of the exact anatomic location of sentinel 
nodes for the successful identification of SLNs. Even-Sapir et al. reported 
that SPECT/CT SLN mapping provided additional data that are of clinical 
relevance to SLN biopsy and added clinically relevant data for 4 of 9 patients 
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with head and neck tumor and 6 of 12 patients with trunk melanoma [10]. 
Van der Ploeg et al. showed that SPECT/CT enabled the visualization of 
drainage in patients in whom planar imaging did not detect SLNs. These 
authors reported that SPECT/CT enabled visualization of lymphatic 
drainage in 123 (92%) of 134 patients [11]. Lerman et al. reported that the 
difference between SLN detection by planar imaging and SLN detection by 
SPECT/CT in overweight and obese patients was statistically significant. 
SPECT/CT identified hot nodes in 91% of the study cohort, including 29 
patients for whom planar imaging failed to detect hot nodes [12]. They also 
reported that planar imaging alone was negative for identification of hot 
nodes in 15% of the patients. SPECT/CT alone was negative in 10% and both 
techniques were negative in 9% of the patients. Forty-six of a total of 361 
(13%) hot nodes identified by lymphoscintigraphy were detected only on 
SPECT/CT, including 21 nodes obscured by the scattered radiation from the 
injection sites [13]. 
Image quality is greatly affected by scattered radiation because 
injection sites with high levels of radioactivity exist near the lymph node 
with low levels of radioactivity. Additionally, SPECT/CT systems provide an 
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accurate AC of the nuclear medicine image data [14]. Therefore, we have 
applied AC and SC to improve the detectability. However, in our experience, 
although the SLNs could be detected in planar images, they sometimes 
disappeared in SPECT/CT images. These corrections may even cause 
artifacts near the injection sites. The counts of SLNs increased when using 
the AC, especially deeply situated SLNs. Our results showed that AC might 
improve the detection of SLNs, especially for deeply situated SLNs. When 
the nodes are close to the body surface, the effect of AC was relatively small. 
The counts of SLNs decreased when using the SC, especially near the 
injection sites. A faint SLN near injection sites might disappear because of 
the SC. When SC was applied, an SLN became invisible in some cases. 
Therefore, we do not recommend that SC is performed. The high detection 
rate and high confidence levels of interpretation suggest that AC+SC- was 
the optimal combination of AC and SC. At the confidence levels of 
interpretation, a significant difference was not observed between AC+SC- 
and planar images. We need to perform both planar imaging and SPECT/CT 
imaging for better visualization and localization of SLNs. Although the AC 
caused artifacts on the border of the lung and the breast, the SPECT/CT 
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images could rule out these artifacts. 
In one case, SLNs could not be detected in both the planar image 
and the SPECT/CT fused image, but could be identified with the gamma 
probe during surgery. Williams et al. reported that some SLNs may not be 
visualized until late in the study. Exercise or muscle contractions could 
facilitate lymphatic flow. Even when regional movement of the affected limb 
causes stagnation in the injection sites, such procedures can improve the 
lymphatic flow [15]. Histopathologic examination detected metastasis in the 
SLNs that were not detected in lymphoscintigraphy. Noguchi reported that 
the SLN counts in metastasis-positive lymph nodes were significantly lower 
than that those in metastasis-negative lymph nodes [16]. 
When the SLNs are located close to the injection sites, techniques 
for reducing the artifacts from the injection sites are important. Therefore, 
we applied the pixel truncation method [17] and the ordered subset 
expectation maximization reconstruction algorithm [18]. These techniques 
reduce the artifacts in scintigraphy. We used the LMEGP collimator for 
reducing the star-shaped artifacts. The LMEGP collimator improved the 
detection of SLNs, particularly in SLNs located close to the injection sites 
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compared with the low-energy high-resolution (LEHR) collimator [19]. 
Recently, resolution correction has been performed for SPECT reconstruction 
[20-22]. When the resolution correction was applied, the resolutions of 
LMEGP and LEHR became similar. We therefore recommend routine use of 
LEMGP collimator for lymphoscintigraphy with SPECT/CT systems. 
  
CONCLUSION 
AC improved the detection of SLNs. SC should not be performed 
because it occasionally caused a faint SLN to become invisible. The 
combination with AC and without SC was recommended to improve the 
detectability, because of the high detection rate and the high confidence 
levels of interpretation. 
 
REFERENCES  
1. van der Ploeg IM, Valdes Olmos RA, Nieweg OE, Rutgers EJ, Kroon BB, Hoefnagel 
CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and 
melanoma. J Nucl Med. 2007;48:1756-60. 
2. Husarik DB, Steinert HC. Single-photon emission computed tomography/computed 
tomographyfor sentinel node mapping in breast cancer. Semin Nucl Med. 
2007;37:29-33. 
3. van der Ploeg IM, Olmos RA, Kroon BB, Rutgers EJ, Nieweg OE. The hidden 
sentinel node and SPECT/CT in breast cancer patients. Eur J Nucl Med Mol 
Imaging. 2009;36:6-11. 
14 
4. Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J 
Nucl Med. 2008;49:1305-19. 
5. Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O, et al. A review on the 
clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging. 2010;37:1959-85. 
6. Laetitia V, Ohnona J, Groheux D, Slama A, Colletti PM, Chondrogiannis S, et al. 
Role of SPECT/CT in sentinel lymph node detection in patients with breast cancer. 
Clin Nucl Med. 2014;39:431-6. 
7. Moncayo VM, Aarsvold JN, Grant SF, Bartley SC, Alazraki NP. Status of sentinel 
lymph node for breast cancer. Semin Nucl Med. 2013;43:281-93. 
8. Sadrmomtaz A, Asl MN. Reliability of scatter correction methods in SPECT by 
setting two energy windows. World Applied Programming. 2011;1:143-9. 
9. de Nijs R, Lagerburg V, Klausen TL, Holm S. Improving quantitative dosimetry in 
(177)Lu-DOTATATE SPECT by energy window-based scatter corrections. Nucl Med 
Commun. 2014;35:522-33. 
10. Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al. 
Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J 
Nucl Med. 2003;44:1413-20. 
11. van der Ploeg IM, Nieweg OE, Kroon BB, Rutgers EJ, Baas-Vrancken Peeters MJ, 
Vogel WV, et al. The yield of SPECT/CT for anatomical lymphatic mapping in 
patients with breast cancer. Eur J Nucl Med Mol Imaging. 2009;36:903-9. 
12. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved 
sentinel node identification by SPECT/CT in overweight patients with breast cancer. 
J Nucl Med. 2007;48:201-6. 
13. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. 
Lymphoscintigraphic sentinel node identification in patients with breast cancer: the 
role of SPECT-CT. Eur J Nucl Med Mol Imaging. 2006;33:329-37. 
14. Patton JA, Turkington TG. SPECT/CT physical principles and attenuation 
correction. J Nucl Med Technol. 2008;36:1-10. 
15. S.Williams B, Hinkle GH, Douthit RA, Fry JP, Pozderac RV, Olsen JO. 
Lymphoscintigraphy and intraoperative lymphatic mapping of sentinel lymph nodes 
in melanoma patients. J Nucl Med Technol. 1999;27:309-17. 
16. Noguchi A, Onoguchi M, Ohnishi T, Hashizume T, Kajita A, Funauchi M, et al. 
Predicting sentinel lymph node metastasis in breast cancer with lymphoscintigraphy. 
Ann Nucl Med. 2011;25:221-6. 
17. Funahashi M, Shimonagata T, Mihara K, Kashiyama K, Shimizu R, Machida S, et al. 
Application of pixel truncation to reduce intensity artifacts in myocardial SPECT 
imaging with Tc-99m tetrofosmin. J Nucl Cardiol. 2002;9:622-31. 
15 
18. Leong LK, Kruger RL, O'Connor MK. A comparison of the uniformity requirements 
for SPECT Image reconstruction using FBP and OSEM techniques. J Nucl Med 
Technol. 2001;29:79-83. 
19. Yoneyama H, Tsushima H, Kobayashi M, Onoguchi M, Nakajima K, Kinuya S. 
Improved detection of sentinel lymph nodes in SPECT/CT images acquired using a 
low-to medium-energy general-purpose collimator. Clin Nucl Med. 2014;39:e1-6. 
20. Yokoi T, Shinohara H, Onishi H. Performance evaluation of OSEM reconstruction 
algorithm incorporating three-dimensional distance-dependent resolution 
compensation for brain SPECT: A simulation study. Ann Nucl Med. 2002;16:11-8. 
21. Takahashi Y, Murase K, Mochizuki T, Sugawara Y, Maeda H, Kinda A. 
Simultaneous 3-dimensional resolution correction in SPECT reconstruction with an 
ordered-subsets expectation maximization algorithm. J Nucl Med Technol. 
2007;35:34-8. 
22. Okuda K, Nakajima K, Yamada M, Wakabayashi H, Ichikawa H, Arai H, et al. 
Optimization of iterative reconstruction parameters with attenuation correction, 
scatter correction and resolution recovery in myocardial perfusion SPECT/CT. Ann 
Nucl Med. 2014;28:60-8. 
 
Legends for illustrations 
Table 1  Detection rate for sentinel lymph nodes in planar and SPECT/CT 
images with and without attenuation correction and scatter correction. 
Table 2  Average counts (mean ± standard deviation: SD) of SLNs in 
SPECT/CT images with and without attenuation correction and scatter 
correction.  
 
Fig. 1  Comparison of confidence levels of interpretation in planar and 
SPECT/CT images with and without attenuation correction (AC) and scatter 
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correction (SC). 
Fig. 2  Relation between distance from SLNs to body surface and effect of 
the attenuation correction. 
Fig. 3  Relation between distance from injection sites to SLNs and effect of 
the scatter correction. 
Fig. 4  SPECT/CT fused images and maximum-intensity projection (MIP) 
images of a 77-year-old female patient. The SPECT/CT (A) and MIP (B) 
images with AC+SC+, AC-SC+ (C, D), AC+SC- (E, F), and AC-SC- (G, H). 
A planar image obtained 3 hours after injection (I). 
Fig. 5  SPECT/CT fused images and maximum intensity projection (MIP) 
images of a 79-year-old female patient. The SPECT/CT (A) and MIP (B) 
images with AC+SC+, AC-SC+ (C, D), AC+SC- (E, F), and AC-SC- (G, H). 
A planar image obtained 3 hours after injection (I). 
Fig. 6  A planar image of a 71-year-old female patients. Although SLNs 
could not be clearly detected in lymphoscintigraphy, they could be identified 
with the gamma probe during surgery. 
Fig. 7  A planar image and SPECT/CT fused images of a 67-year-old female 
patient. Although axillary SLNs near injection sites could not be clearly 
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detected in the planar image obtained 3 hours after injection (A), they could 
be detected in the planar image obtained 4 hours after injection (D). They 
could not be detected using SPECT/CT fused image with AC-SC+ (B) and 
AC+SC+ (C) obtained 4 hours after injection, but they were detected using 
SPECT/CT fused image with AC+SC- (E) and AC-SC- (F) obtained 4 hours 
after injection. 
Fig. 8  A planar image and SPECT/CT fused images of a 73-year-old female 
patient. Although axillary SLNs near injection sites could not be clearly 
detected in the planar image (A) and the SPECT/CT fused image with 
AC-SC+ (B) and AC+SC+ (C), they were detected using SPECT/CT fused 
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